
Hear first-hand from regulators on updates in the post pandemic world
Event covers global clinical trials, bioequivalence and pharmacovigilance
Event covers global clinical trials, bioequivalence and pharmacovigilance
New medication for adults with this rare blood disorder
Analysis shows switching is not associated with major safety events
Learn how the agency uses science and data to ensure drug safety, quality and efficacy
FDA will discuss therapeutic protein products, gastric pH level and more
Study can help in the development and approval of generic nasal drugs
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.